IL-2 Receptor Antagonist (Basiliximab) Is Associated with Rapid Fibrosis Progression in Patients with Recurrent Hepatitis C after Liver Transplantation Using Serial Biopsy Specimen...

Por Hanouneh, I. A., Zein, N. N., Lopez, R., Yerian, L., Fung, J., Eghtesad, B.
Publicado em 2010

Recurrence of Disease Following Liver Transplantation: Nonalcoholic Steatohepatitis vs Hepatitis C Virus Infection

Por Hanouneh, I. A., Macaron, C., Lopez, R., Feldstein, A. E., Yerian, L., Eghtesad, B., Zein, N. N.
Publicado em 2011

Treatment of Recurrent Hepatitis C Genotype-4 Post-Liver Transplantation with Sofosbuvir plus Simeprevir

Por Ascha, Mustafa, Ascha, Mona, Zein, N. N., Alkhouri, N., Eghtesad, B., Abu-Elmagd, K., Diago, T., Hanouneh, I. A.
Publicado no Int J Organ Transplant Med (2015)

Sofosbuvir and Simeprevir for the Treatment of Recurrent Hepatitis C with Fibrosing Cholestatic Hepatitis after Liver Transplantation

Por Issa, D., Eghtesad, B., Zein, N. N., Yerian, L., Cruise, M., Alkhouri, N., Adams, R., Hanouneh, I. A.
Publicado no Int J Organ Transplant Med (2016)

The Incidence and Risk Factors of De Novo Skin Cancer in the Liver Transplant Recipients

Por Modaresi Esfeh, J., Hanouneh, I.A., Dalal, D., Tabba, A., Lopez, R., Pagadala, M., Eghtesad, B., Zein, N.N
Publicado em 2012